Carbohydrate-deficient transferrin in the assessment of harmful alcohol consumption: diagnostic performance and clinical significance
Author:
- 1 April 1999
- journal article
- Published by Wiley in Addiction Biology
- Vol. 4 (2) , 151-161
Abstract
The last decade saw the emergence of carbohydrate-deficient transferrin (CDT) as the most promising marker for the diagnosis of alcohol abuse. Daily alcohol consumption of four beers, four glasses of wine or three standard drinks causes increased concentrations of CDT in serum. CDT is serum transferrin with a reduced content of oligosaccharides due to the detrimental effects of alcohol metabolism on the glycosylation pathway of hepatocytes and/or the increased activity of circulating glycosidases in serum. Most current CDT procedures entail separation of normal transferrin from CDT in a charged matrix-like isoelectric focusing and ion exchange chromatography, followed by detection/quantitation of CDT by a myriad of immunoassays: immunoblotting, radioimmunoassay, enzyme immunoassay and nephelometry. New CDT procedures present the advantages of improved performance, inexpensive automation and CDT results expressed as a percentage of total serum transferrin. CDT's major asset is its high specificity in well-defined populations i.e. individuals ingesting 60 g alcohol daily for at least a week.The sensitivity rates, which vary between 22% and 81%, depend on the amount of alcohol ingested, time of sample collection after the cessation of drinking, age, gender and the cut-off point chosen for analysis of tests' results. Regarding clinical applications, best outcome is achieved when the test is used to confirm a suspicion of alcohol abuse and when monitoring abstinence and relapses.The low prevalence of alcohol abuse in the general population challenges its use as a screening test.With the advent of inexpensive automation and the constant emergence of innovative, improved tests, we are seeing the rise of a new era in alcohol abuse diagnosis as affordability and education allows widespread use of CDT in a variety of settings.Keywords
This publication has 33 references indexed in Scilit:
- Carbohydrate‐Deficient Transferrin as an Indicator of Drinking Status During a Treatment Outcome StudyAlcohol, Clinical and Experimental Research, 1996
- Elevated levels of serum carbohydrate deficient transferrin are not specific for alcohol abuse in patients with liver diseaseJournal of Hepatology, 1995
- Carbohydrate‐Deficient Transferrin in Alcohol and Nonalcohol Abusers with Liver DiseaseAlcohol, Clinical and Experimental Research, 1995
- Carbohydrate-Deficient Transferrin as a Marker of Alcohol Abuse: Relationship to Alcohol Consumption, Severity of Liver Disease, and FibrogenesisAlcohol, Clinical and Experimental Research, 1995
- Detection of Relapses in Alcohol‐Dependent Patients Using Carbohydrate‐Deficient Transferrin: Improvement with Individualized Reference Levels during Long‐Term MonitoringAlcohol, Clinical and Experimental Research, 1995
- Carbohydrate‐Deficient Transferrin–A Valid Marker of Alcoholism in Population Studies? Results from the Copenhagen City Heart StudyAlcohol, Clinical and Experimental Research, 1995
- Carbohydrate‐Deficient Transferrin Levels in a Female PopulationAlcohol, Clinical and Experimental Research, 1995
- Carbohydrate‐Deficient Transferrin and γ‐Glutamyltransferase as Markers of Heavy Alcohol Consumption: Gender DifferencesAlcohol, Clinical and Experimental Research, 1994
- Carbohydrate‐Deficient Transferrin During 3 Weeks' Heavy Alcohol ConsumptionAlcohol, Clinical and Experimental Research, 1994
- A New Approach to Quantitate Carbohydrate‐Deficient Transferrin Isoforms in Alcohol Abusers: Partial Iron Saturation in Isoelectric Focusing/Immunoblotting and Laser DensitometryAlcohol, Clinical and Experimental Research, 1993